SCHEMBL7844614

SCHEMBL7844614

[CH2]c1ccc(NC(=O)c2cc(Cl)ccc2NS(=O)(=O)c2ccc(Cl)cc2)cc1

nearest known ligand 0.72

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ SLC10A6 Q3KNW5 3/20 0.72
▸ SLC10A2 Q12908 2/20 0.72
▸ SLC10A1 Q14973 2/20 0.72
▸ GPR27 Q9NS67 8/20 0.60
▸ KDM4E B2RXH2 1/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ KMT2A Q03164 1/20 0.57
▸ KCNA5 P22460 1/20 0.57
▸ AVPR2 P30518 2/20 0.56
▸ GAA P10253 1/20 0.53
▸ ALDH1A1 P00352 1/20 0.52
▸ LMNA P02545 1/20 0.52
▸ POLB P06746 1/20 0.52
▸ METAP2 P50579 2/20 0.51
▸ ACLY P53396 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6754585 0.94 SLC10A6 (0.81) SLC10A6SLC10A2SLC10A1GPR27KDM4E
SCHEMBL6760783 0.89 SLC10A6 (0.74) SLC10A6SLC10A2SLC10A1GPR27KDM4E
SCHEMBL491625 0.88 SLC10A6 (0.72) SLC10A6SLC10A2SLC10A1GPR27KDM4E
SCHEMBL5115455 0.88 SLC10A6 (0.88) SLC10A6SLC10A2SLC10A1GPR27KDM4E
SCHEMBL491711 0.88 SLC10A6 (0.72) SLC10A6SLC10A2SLC10A1GPR27KDM4E
SCHEMBL492157 0.88 SLC10A6 (0.72) SLC10A6SLC10A2SLC10A1GPR27KDM4E
SCHEMBL5126855 0.87 SLC10A6 (0.71) SLC10A6SLC10A2SLC10A1GPR27KDM4E
SCHEMBL6862400 0.87 SLC10A6 (0.71) SLC10A6SLC10A2SLC10A1GPR27KDM4E
SCHEMBL5126186 0.86 SLC10A6 (0.69) SLC10A6SLC10A2SLC10A1GPR27KDM4E
SCHEMBL5126790 0.86 SLC10A6 (0.69) SLC10A6SLC10A2SLC10A1GPR27KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125932-A2 Substituted thiazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-22 — — EP disclosed
EP-1095015-A2 SULFONYLAMINO CARBOXYLIC ACID N-ARYLAMIDES AS GUANYLATE CYCLASE ACTIVATORS Aventis Pharma Deutschland GmbH (DE) 2001-05-02 — — EP disclosed
WO-2000002850-A2 SULFONYLAMINO CARBOXYLIC ACID N-ARYLAMIDES AS GUANYLATE CYCLASE ACTIVATORS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2000-01-20 — — WO disclosed
Send feedback